



The VAMP-associated protein VAPB is required for
cardiac and neuronal pacemaker channel function
Silbernagel, Nicole; Walecki, Magdalena ; Schafer, Martin K -H; Kessler, Mirjam; Zobeiri,
Mehrnoush; Rinné, Susanne; Kiper, Aytug K; Komadowski, Marlene A; Vowinkel, Kirsty S;
Wemhoner, Konstantin; Fortmüller, Lisa; Schewe, Marcus ; Dolga, Amalia M; Scekic-
Zahirovic, Jelena ; Matschke, Lina A; Culmsee, Carsten; Baukrowitz, Thomas; Monassier,




Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Silbernagel, N, Walecki, M, Schafer, MK-H, Kessler, M, Zobeiri, M, Rinné, S, Kiper, AK, Komadowski, MA,
Vowinkel, KS, Wemhoner, K, Fortmüller, L, Schewe, M, Dolga, AM, Scekic-Zahirovic, J, Matschke, LA, Culmsee,
C, Baukrowitz, T, Monassier, L, Ullrich, ND, Dupuis, L, Just, S, Budde, T, Fabritz, L & Decher, N 2018, 'The
VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function', FASEB
Journal, vol. 32, no. 11. https://doi.org/10.1096/fj.201800246R
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
THE
JOURNAL • RESEARCH • www.fasebj.org
The VAMP-associated protein VAPB is required for
cardiac and neuronal pacemaker channel function
Nicole Silbernagel,* Magdalena Walecki,* Martin K.-H. Scha¨fer,† Mirjam Kessler,‡ Mehrnoush Zobeiri,§
Susanne Rinne´,* Aytug K. Kiper,* Marlene A. Komadowski,*,† Kirsty S. Vowinkel,* Konstantin Wemho¨ner,*
Lisa Fortmu¨ller,{ Marcus Schewe,k Amalia M. Dolga,# Jelena Scekic-Zahirovic,** Lina A. Matschke,*
Carsten Culmsee,# Thomas Baukrowitz,k Laurent Monassier,** Nina D. Ullrich,†† Luc Dupuis,‡‡,§§
Steffen Just,‡ Thomas Budde,§ Larissa Fabritz,{,{{,kk,##,*** and Niels Decher*,1
*Institute of Physiology and Pathophysiology, Vegetative Physiology, †Institute of Anatomy and Cell Biology, and #Institute of Pharmacology and
Clinical Pharmacy, Phillips University, Marburg, Germany; ‡Molecular Cardiology, Department of Internal Medicine II, University Hospital Ulm,
Ulm, Germany; {Department of Cardiology II - Electrophysiology, ##Division of Rhythmology, and ***Institute of Human Genetics, Department of
Genetic Epidemiology, University Hospital Mu¨nster, and §Institute for Physiology I, University of Mu¨nster, Munster, Germany; kInstitute of
Physiology, Christian-Albrechts University, Kiel, Germany; **Laboratoire de Pharmacologie et Toxicologie NeuroCardiovasculaire, ‡‡Laboratoire de
Neurobiologie et Pharmacologie Cardiovasculaire, and §§INSERM, Faculte´ de Me´decine, Universite´ de Strasbourg, Strasbourg, France; ††Institute of
Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany; and {{Institute of Cardiovascular Sciences and kkDepartment of
Cardiology, University Hospital Birmingham, University of Birmingham, Birmingham, United Kingdom
ABSTRACT: Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels encode neuronal and cardiac pace-
maker currents. The composition of pacemaker channel complexes in different tissues is poorly understood, and the
presence of additional HCNmodulating subunits was speculated. Here we show that vesicle-associated membrane
protein–associated protein B (VAPB), previously associatedwith a familial form of amyotrophic lateral sclerosis 8, is
an essential HCN1 and HCN2modulator. VAPB significantly increases HCN2 currents and surface expression and
hasamajor influenceon thedendriticneuronaldistributionofHCN2.Severe cardiacbradycardias inVAPB-deficient
zebrafish andVAPB2/2mice highlight that VAPBphysiologically serves to increase cardiac pacemaker currents. An
altered T-wave morphology observed in the ECGs of VAPB2/2 mice supports the recently proposed role of HCN
channels for ventricular repolarization.The critical functionofVAPB innativepacemaker channel complexeswill be
relevant forourunderstandingof cardiacarrhythmiasandepilepsies, andprovidesanunexpected linkbetween these
diseases and amyotrophic lateral sclerosis.—Silbernagel,N.,Walecki,M., Scha¨fer,M.-K.H.,Kessler,M., Zobeiri,M.,
Rinne´, S., Kiper, A. K., Komadowski,M. A., Vowinkel, K. S.,Wemho¨ner, K., Fortmu¨ller, L., Schewe, M., Dolga, A.
M., Scekic-Zahirovic, J., Matschke, L. A., Culmsee, C., Baukrowitz, T.,Monassier, L., Ullrich, N. D., Dupuis, L.,
Just, S., Budde, T., Fabritz, L., Decher, N. The VAMP-associated protein VAPB is required for cardiac and
neuronal pacemaker channel function. FASEB J. 32, 6159–6173 (2018). www.fasebj.org
KEY WORDS: HCN channels • ALS • cardiac arrhythmia
Hyperpolarization-activated cyclic nucleotide-gated (HCN)
channels play a major role in generating neuronal and
cardiac automaticity (1). Upon hyperpolarization, HCN
channels induce an unspecific cationic conductance,
mediated by Na+ and K+ (2), described as Ih and Iq in the
brain or If in the heart. These pacemaker currents regulate
the heart rate (3), as well as rhythmic activity in neuronal
circuits (4, 5) and synaptic transmission (6) but are also
ABBREVIATIONS: ALS, amyotrophic lateral sclerosis; CC, coiled-coil; CNBD, cyclic nucleotide–binding domain; DIG, digoxigenin; ECG, electrocar-
diogram; GFP, green fluorescent protein; GST, glutathione S-transferase; HA, hemagglutinin; HCN, hyperpolarization-activated cyclic nucleotide-gated;
hpf, hours postfertilization; iPSC-CM, induced pluripotent stem cell–derived cardiomyocyte; ISH, in situ hybridization; I–V, current–voltage; MO,
morpholino-modified antisense oligonucleotide; MSP, major sperm region; Pir, piriform cortex; shRNA, short hairpin RNA; SSC, saline-sodium citrate;
SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; TEVC, two-electrode voltage-clamp; TM, transmembrane; VAMP, vesicle-
associated membrane protein; VAPB, VAMP-associated protein B; Y2H, yeast 2-hybrid
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important for setting therestingmembranepotential (7).The
conserved cyclic nucleotide–bindingdomain (CNBD) in the
C terminus of HCN channels (8) confers a cAMP sensitivity
to the channels (9, 10) that can be antagonized by allosteric
competitionwith the auxiliaryHCNsubunit Trip8b (11, 12).
However, remainingdifferences in voltagedependence and
pharmacology of pacemaker currents in native tissues to-
ward the 4 known HCN channels suggest the presence of
additional HCN channel–modulating proteins.
The present article describes a novel interaction part-
ner and modulator of HCN1 and HCN2, the vesicle-
associatedmembraneprotein (VAMP)-associatedproteinB
(VAPB or ERG30) (13). VAPs were initially described as
interacting partners of VAMP, participating in neuro-
transmitter release (14). VAPs are, in addition to the
endoplasmic reticulum, found in many intracellular com-
partments including, for example, the Golgi apparatus,
recycling endosomes, and tight junctions, but also the
plasma membrane (15, 16). Both family members, VAPA
(VAP-33) (17) and VAPB, form a complex via their trans-
membrane (TM) domains and are part of the vesicle
(v)-synaptosome-associated protein receptor (SNARE)
complex (16). Ithasbeenproposed thatVAPB isnotdirectly
participating in synaptic vesicle exocytosis but rather in the
targeting of components to the synaptic terminals (18). In
addition, previous studies ofKv2.1 andVAMP (19), TASK-
1 and syntaxin 8 (20), or GLUT4 and VAPA (15) indicated
that components of the v-SNARE or target (t)-SNARE
complex (t-SNARE) might have functions in addition to
regulating exocytosis, as they modulate channels or trans-
porters that are integral to the surface/cell membrane.
MATERIALS AND METHODS
Split-ubiquitin yeast 2-hybrid experiments
Asplit-ubiquitin yeast 2-hybrid (Y2H)membraneprotein system
(Y2H Membrane Protein Kit; MoBiTec, Go¨ttingen, Germany)
wasused for screening aNubG fusedhumanbrain cDNAlibrary
in the yeast strain NMY51 to identify potential interaction part-
ners of HCN2. For this purpose, full-length mHCN2 was sub-
cloned by SfiI restriction sites into the bait vector pBT3-N
according to the instruction manual (MoBiTec). pAl-Alg5 was
used as positive control and pPR3-N as negative control. Yeast
cloneswere selectedbyactivationof reporter genesuponpositive
interaction of bait (pBT3-mHCN2) and prey (NubG-x fused
cDNA library) encoding 2 auxotrophic growth markers (HIS3
andADE2).Activation of reporter genes concedes yeast clones to
grow on minimal medium lacking histidine (H), adenine (A),
leucine (L), and tryptophan (W) for selection (-LWHAmedium).
Further selection for the strongest interactors was performed by
using a b-galactosidase assay due to the property of positive col-
onies expressing the protein b-galactosidase. Isolated plasmid-
DNA of positive yeast colonies was analyzed by sequencing. For
the confirmation of interaction, a split ubiquitin Y2H direct in-
teraction assaywas performed. Therefore, full-length hVAPBwas
subcloned via SfiI restriction sites into the prey vector pPR3-N and
tested for an interaction with pBT3-mHCN2 or pBT3-hHCN4 by
validation of colony growth on minimal medium (-LWHA).
Expression constructs
For oocyte expression, hHCN1, mHCN2, hHCN4, and hVAPB
were subcloned into pSGEM. NTKHCN2 was cloned into ALMV
vector and mHCN2HAEx into pBF1. cRNAwas prepared with an
mMessage mMachine T7 or SP6 Kit (Thermo Fisher Scientific,
Waltham, MA, USA) after linearization. The QuikChange Site-
Directed Mutagenesis Kit (Stratagene; Biocompare, South San
Francisco, CA, USA) was used to introduce specific mutations.
hVAPB, hVAPA, hVAMP1, and hVAMP2 were subcloned in
frame into the pGEX-4T-1 vector (Amersham; GE Healthcare,
Freiburg, Germany) for glutathione S-transferase (GST) fusion
proteinexpression inBL21cells.VAPBandVAPAweresubcloned
via EcoRI and SalI, whereas VAMP1 and VAMP2were subcloned
withBamHI andEcoRI. Constructs formammalian cell expression
were subcloned in pEGFP, pDsRed, or pcDNA3.1(+) vectors.
GST pull-down experiments
GST fusion proteins were obtained after lysis of 1 ml BL21 cell
culture. Protein expression was induced at 0.4–0.6 OD600 by
1 mM isopropyl b-d-thiogalactopyranoside for 3 h at 37°C.
Protein extraction of a 1-ml culture was performed by using
200 ml RIPA buffer supplemented with 4 ml protease inhibitor
cocktail (Sigma-Aldrich, Merck, Mu¨nchen, Germany) and 1%
lysozyme. Six freeze and thaw cycles were performed to im-
prove the protein yield. HCN2 protein was prepared by lysis of
HeLa cells transfected with 2 mg HCN2EGFP. HeLa cells were
harvested 48 h after transfection, washed in PBS, and lysed
30min on ice using 200ml RIPA buffer supplementedwith 10ml
protease inhibitor cocktail (Sigma-Aldrich). Insoluble material
was separated by centrifugation (13,000 rpm for 15 min at 4°C).
The TnT Quick Coupled Transcription/Translation System (T7;
Promega, Madison, WI, USA) was used to synthesize in vitro
translated HCN2 based on HCN2 pcDNA3.1 plasmid using T7
promotor. Pull-down experiments were performed following
the MagneGST Pull-Down System (Promega) manual. Proteins
were eluted frommagnetic beads 2 timeswith 20ml SDS sample
buffer. For separation of the proteins by SDS-PAGE, pull-downs
were heat denatured at 40°C for 10 min. After centrifugation at
5000 rpm for 3 min, protein lysates were separated on an 8%
SDS-polyacrylamide gel. The input was diluted 1:15 and 1:10.
Proteins were transferred to a nitrocellulose membrane via a
Semi-Dry Transfer Cell (Bio-Rad, Munich, Germany) at 70 mA
for 1 h. For GST pull-downs with HCN2EGFP, the HCN2 protein
was visualized by immunoblotting with mouse a–green fluo-
rescent protein (GFP) antibody (ab290, 1:5000; Abcam, Cam-
bridge, United Kingdom). The binding of the primary antibody
was detected by using peroxidase-conjugated goat a-rabbit IgG
antibody (32460, 1:2000; Pierce, Thermo Fisher Scientific) and a
chemiluminescent extended-duration substrate (Super Signal
West Dura; Thermo Fisher Scientific). Untagged HCN2 protein
was detected with rabbit a-HCN2 antibody (APC-030, 1:300;
Alomone Labs, Jerusalem, Israel) and peroxidase-conjugated
goat a-rabbit IgG antibody (32460, 1:2000; Thermo Fisher Sci-
entific) as the secondary antibody.
Two-electrode voltage-clamp measurements in
Xenopus oocytes
Isolation of Xenopus laevis oocytes and two-electrode voltage-
clamp (TEVC) recordings were performed as previously de-
scribed (21). Stage IV and V oocytes were injected with 7.5 ng of
HCN2 cRNAor coinjectedwith 1 ngofVAPB,VAPBP56S, VAPA,
VAPC, VAMP1, and VAMP2, as well as 1 ng of the following
VAPB mutations: TMVAPB, MSPVAPB, MSP-CC0.5
VAPB, and
MSP-CCVAPB. For the C-terminal deletion constructs, 3.5 ng
NTKHCN2,HCN2F530*, andHCN2V628* or 15 ng ofHCN2F486*were
coexpressed with 1 ng VAPB. To determine selectivity
withinHCN-channel familymembers, 3.5 ngHCN1 or 15 ng
HCN4 cRNA was coexpressed with 1 ng VAPB; 3.5 ng
HCN2 was coexpressed with 0.25 ng VAPA/B complex.
6160 Vol. 32 November 2018 SILBERNAGEL ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by Univ of Birmingham Barnes Medical Library (147.188.108.18) on August 27, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 6159-6173.
TEVC experiments were performed in ND96 solution,
containing (mM): NaCl 96, KCl 2, CaCl2 1.8, MgCl2 1,
HEPES 5; pH 7.4, 2 d after injection of the respective con-
structs. ND66 solution, containing (mM): NaCl 66, KCl 32,
CaCl2 1.8, MgCl2 1, HEPES 5; pH 7.4, was used for the
coexpression experiments ofVAPBwithHCN4,HCN2F486*, and
the complexmeasurements ofHCN2andVAPA/B, due to small
current amplitudes.Current–voltage (I–V) curveswere recorded
by 2 s voltage steps to potentials ranging from230 to2140 mV
froma holdingpotential of230mV. Tail currentswere recorded
by a 750 ms test pulse to2130 mV.
Inside-out macropatch-clamp recordings from
X. laevis oocytes
Giant patch recordings in the inside-out configuration under
voltage-clamp conditions were made at room temperature
(22–24°C). Pipettes were made from thick-walled borosilicate
glass, had resistances of 0.3–0.5 MV (tip diameter of 5–15 mm),
andwere filledwith a pipette solution containing (mM):KCl 120,
HEPES10andCaCl2 1.0; pH7.2. Bath solutionshad the following
composition (mM):KCl 100,HEPES 10,K2EGTA10; pH7.2. Bath
solutions were applied via a multibarrel pipette system to the
cytoplasmic side of excised membrane patches. Currents were
recorded with an EPC10 amplifier (Heka Electronik, Lambrecht,
Germany), and capacitive transients were compensated with an
automated circuit of the EPC10.
Fluorescence microscopy
HeLa or HL-1 cells were grown on 35 mm glass bottom Petri
dishes (WillCo,Amsterdam, TheNetherlands) to a confluency of
;50%. HeLa cells were grown in DMEM medium containing
10% fetal bovine serum (Thermo Fisher Scientific) and 1% Pen
Strep (Thermo Fisher Scientific). After 24 h, HeLa cells
were transfected with either 1 mg EGFP-C1-HCN2-HAEx
(EGFPHCN2HAEx) or cotransfected with VAPB pcDNA3.1 or
TMVAPB pcDNA3.1 per dish using jetPrime (Peqlab, Erlangen,
Germany).Cellsweremaintainedat37°C for6–48haeratedwith
5% CO2. For fluorescence imaging, HL-1 cells were fixed with
methanol, whereas for HeLa cells, live cell imaging in an HBSS
buffer (Thermo Fisher Scientific) was performed. Fixed HL-1
cells were stained with an a-VAPB antibody (sc-98992, 1:50;
Santa Cruz Biotechnology, Heidelberg, Germany) after per-
meabilization (0.25% Triton-X-100/PBS) and blocking with 3%
goat serum/PBS. For visualization, an Alexa Fluor 488 goat
a-rabbit antibody (A11008, 1:200; Thermo Fisher Scientific) was
used. Fluorescence microscopy was performed with an Olym-
pus IX71 microscope equipped with a 360 N.A. 1.3 PL APO
objective or a 1003 N.A. 1.4 PL APO objective (Olympus,
Hamburg, Germany), standard EGFP/Texas Red filter sets, and
a cooled 12-bit CCD camera (SensiCam QE; Cooke, Auburn
Hills, MI, USA). During live cell imaging, cells weremaintained
at 37°C using an objective heater (Bioptechs, Butler, PA, USA).
Digital images were processed by using Image-Pro Plus 6.0
(Media Cybernetics, Cambridge, United Kingdom).
Analyses of channel surface expression in oocytes
and HeLa cells and Western blot analysis
X. laevis oocytes were injected with 10 ng HCN2HAEx cRNA
transcribed frompBF1 alone or coexpressedwith 1 ngVAPB48h
before surface expression analysis. Subsequently, a chemi-
luminescence assaywas performed as previously described (21).
For surface expression studies inHeLa cells, cellswere grown
to a confluency of 90% and transfected with either 1 mg
EGFPHCN2HAEx alone or cotransfected with 1 mg VAPB
pcDNA3.1 or TMVAPB pcDNA3.1. Cells were fixed with 4%
paraformaldehyde for 20 min on ice and blocked with 10% nor-
mal goat serum/PBS with 0.1% sodium azide for 1 h at room
temperature. Immunolabeling was performed with an a-HA
antibody (sc-7392, 1:100 in PBS; Santa Cruz Biotechnology) for 1 h
followed by 4 times washing in PBS. After incubation with a
peroxidase-coupled secondary antibody (sc-2005, a-goat, 1:5000;
Santa Cruz Biotechnology), luminescence was measured in a
luminometer (GloMax 20/20; Promega) by addition of chem-
iluminescence substrate (SuperSignal ELISA Femto Maximum
SensitivitySubstrate;ThermoFisherScientific).Peak luminescence
was determined and normalized to EGFPHCN2HAEx mean lumi-
nescence. For determination of the whole-cell protein concentra-
tion, cells were lysed with RIPA buffer as previously described.
Equal amounts of protein lysates verified by Bradford assaywere
separated on a 10% SDS-polyacrylamide gel with Mini-Protean
Tetra Cell (Bio-Rad) at 35 mA and transferred to a nitrocellu-
lose membrane for Western blot analysis. EGFPHCN2HAEx was
detected with an a-GFP antibody (ab290, 1:5000; Abcam).
Preparation and transfection of primary
cortical neurons
Primary cultures of cortical neurons were prepared from em-
bryonic Sprague-Dawley rats (E16) (Rattus norvegicus) essentially
as previously described (22). Primary cortical neurons were
seeded at a density of 200,000 cells/well (24-well plates) onto
polylysine-coated coverslips in Neurobasal-A medium supple-
mented with 2% B27, 1 mg/ml gentamicin, 2 mM GlutaMax
(Thermo Fisher Scientific), and 5% fetal calf serum. After 4 h, this
mediumwas replaced with Neurobasal medium supplemented
with1.2mMglutamine, 2%(v/v)B27 supplement (20ml/L), and
penicillin/streptomycin (0.1 mg/ml), which was used as a cul-
ture medium. Following 3-DIV, neurons were transfected with
1mgHA-taggedVAPB (HAVAPB) or HAVAPBP56S plasmidusing
2ml/ml Lipofectamine 2000 (Thermo Fisher Scientific) according
to the manufacturer’s instructions.
Images were acquired by using a confocal laser scanning
microscope (Leica SP5; LeicaMicrosystems,Wetzlar, Germany).
Light was collected through a 363 1.4 NA oil immersion lens
with an additional32optical zoomapplied fordendritic regions.
For green detection, cells were excited at 488 and 543 nm, and
emissions were detected by using 505–530 band pass filter
(green), Alexa 568 stained HCN2 or VAPB was detected by ex-
citation at 620 nm band pass filter, and emission by using a
690 nm long pass filter (red).
In situ hybridization
To generate specific in situ hybridization (ISH) probes, cDNA
fragments of HCN2 (nt. 1404-1934, NM_008226.2), VAPA (nt.
894-1462, NM_013933.3), and VAPB (nt. 3299- 4320, NM_
019806.5) were obtained by RT-PCR cloning from RNA extracts
of mouse brain and subcloned into pGEM-T (Promega) for in
vitro transcription. Specific primer sets are listed in Supplemental
Table 1. Fourteen-micrometer-thick frozen brain sections were
cut on a Leica cryostat, thaw-mounted on adhesive slides, and
subjected to the prehybridization procedure as described.
Digoxigenin (DIG)-labeled probes in anti-sense and sense ori-
entation were generated from the templates described earlier by
in vitro transcription using SP6 or T7 RNA polymerase in a DIG
labeling mix containing 10 mM each of ATP, CTP, and GTP,
6.5 mM UTP, and 3.5 mM DIG-11-UTP (Roche, Mannheim,
Germany). Riboprobes in sense orientation served as negative
controls. After limited alkaline hydrolysis (0.2 M Na2CO3, pH
10.2), probes were added to the hybridization solution (3 times
saline-sodium citrate [SSC], 50 mM Na3PO4, 10 mM dithio-
threitol, 1 time Denhardt’s Solution, 0.25 g/L yeast tRNA, 10%
dextran sulfate, and 50% formamide) to a final concentration of
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0.1 to 0.5 ng/ml. To each slide, 50 ml hybridization mix was ap-
plied and incubated for 14 h at 60°C. Slides were washed in 23
SSC for 20 min, followed by 30 min RNase A treatment [20 mg
RNaseAand1U/mlRNaseT1(Roche) in10mMTris-HCl,pH8.0,
0.5MNaCl, and 1mMEDTA] at 37°C. The slideswerewashed at
room temperature in decreasing salt concentrations (1, 0.5, and
0.23SSC) for 20mineachandat 60°C in0.23SSC for 1h, followed
bya final rinseat roomtemperature in0.23SSCanddistilledwater
for 10 min each.
For hybrid detection, slides were equilibrated for 30 min at
room temperature in buffer A (100 mM Tris and 150 mM NaCl,
pH 7.5) containing 0.05% Tween 20 (Merck, Darmstadt, Ger-
many) and blocking reagent (Roche). Alkaline phosphatase–
conjugated anti-DIG Fab fragments (11093274910; Roche) were
diluted to 0.25 U/ml in blocking buffer and applied to slides for
2 h at 37°C. Excessive antibody was removed by two 10 min
washes in buffer A. Slides were equilibrated to buffer B (100 mM
Tris, 100mMNaCl, and 50mMMgCl2; pH 9.4) containing 0.05%
Tween 20 for 10min. The chromogen solution containing 0.2mM
5-bromo-4-chloro-3-indolyl phosphate and 0.2 mM nitroblue
tetrazoliumsalt (Roche) inbuffer Bwasapplied for 3h in thedark,
under periodic microscopic monitoring of color development,
until reaction was stopped in water. Slides were embedded in
aqueous mounting medium (Merck). Only adult (3–6 mo) in-
house bred male C57BL6/J mice were used (n = 4). Each ISH
experiment was performed 3 times, and for each brain region
investigated, 9–12 sections (equals 3–4 slides) were hybridized
with anti-sense probes and 6 sections (2 slides) with sense probes.
For analysis and documentation, an OlympusAX70 fluorescence
microscope (Olympus Optical) equipped with a Spot Digital
Camera System (Diagnostics Instruments, Sterling Heights, MI,
USA) was used.
VAPA and VAPB knock-down experiments in
embryonic zebrafish
Zebrafish (Danio rerio) of the Tu¨bingen strain were bred and
maintained at 28.5°C as described by Westerfield (23). Pictures
and movies were recorded at 72 h postfertilization (hpf). Heart
rate was counted at 72 hpf at room temperature. For all injection
procedures for morpholino-modified antisense oligonucleotides
(MO), the TE wild-type strain was used. MO (Gene Tools, Phil-
omath, OR, USA) were directed against the translational start
site (59-TCAGGATCTGCTCCAGTTTGGACAT-39) of zebrafish
VAPA (MOVAPA) and the translational start site (59-CCATCT-
CCCACTGCAAACGCTCGGA-39) of zebrafishVAPB (MOVAPB).
For rescue experiments, sense-capped cRNAs of human wild-
type VAPA as well as wild-type and mutant VAPBP56S were
synthesized by using the mMESSAGE mMACHINE system
(Ambion; Thermo Fisher Scientific). Each cRNA was, with a
concentration of 75 ng/ml, coinjected with MOVAPB or KCl.
Calcium imaging was performed as previously described (24,
25). Wild-type and MOVAPA/VAPB morphant embryos were
injected with 1 nl of a 250 mMstock solution of calcium green-1
dextran (Molecular Probes, Eugene, OR, USA) at the 1-cell
stage. At 72 hpf, videos were recorded with a Proxitronic
(ProxiVision, Bensheim, Germany) camera at 29.97 frames/s.
Relative fluorescence of the atriumandventriclewere analyzed
with custom-made software (26). All zebrafish injection pro-
cedureswere repeated at least 3 times (3 biologic replicates). All
surviving injected embryos per group were subjected to func-
tional analyses at 72 hpf.
Immunostaining of VAPB in embryonic
zebrafish hearts
Dissected hearts of zebrafish embryos at 72 hpf were fixed
in 4% methanol-free formaldehyde in PBS. After blocking
in 10% goat serum in PBS with Tween 20, hearts were in-
cubated with a custom-made rabbit polyclonal anti-mouse
VAPB antibody (1:2000), previously described (27), for
1 h at room temperature. The secondary antibodies were
diluted 1:1000 in PBS with Tween 20 and incubated for
30 min at room temperature. A Zeiss Axioskop 2 plus and
the AxioVision software (Zeiss, Wetzlar, Germany) were
used for documentation.
RT-PCR and ISH
RNAs from embryonic zebrafish hearts were extracted
by using the RNeasy Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Reverse tran-
scription was performed by using SuperScript III Reverse
Transcriptase (Thermo Fisher Scientific). Vapa- and vapb-
specific PCR analyses were performed according to standard
protocols using SYBR-GreenMaster Mix (Roche) and a Roche
LightCycler 480 II.Whole-mount ISHwas performedbyusing
DIG-labeled antisense RNA probes against zebrafish vapa
and vapb as previously described.
Electrocardiograms in VAPB2/2 mice
Noninvasive surface electrocardiogram (ECGs) from adult
VAPB (+/+, +/2, 2/2) mice (C57Bl/6N tac strain) gently re-
strained by an ECG tunnel system (EMKA Technologies, Paris,
France)were recorded by using contact electrodes inserted in the
tunnel floor in conscious mice. VAPB knock-out mice were
backcrossed over 5 generations, andwild-type littermates served
as controls for the experiments. All parameters were measured
from lead I by blinded observers.
Experiments in HL-1 cells
HL-1 cellswere grown on 35mmdishes (Nunc; Thermo Fisher
Scientific) to a confluency of ;50%. Cells in each dish were
either transfected with 2 mg pEGFP vector alone, or in com-
bination with 2 mg VAPB pcDNA3.1(+) or 2 mg pcDNA3.1(+).
For knock-down experiments, HL-1 cells were transfected
with either 2 mg shVAPB-GIPZ or 2 mg shcontrol-GIPZ. For
Western blot analysis of HL-1 cardiomyocytes, the cells were
treated with puromycin to select for transfected cells. After
24 h, HL-1 cells were measured with an EPC10 amplifier
(HEKA Electronik) in the whole-cell configuration at room
temperature (22°C) using previously described solutions (28).
Pipettes had a tip resistance of 2.5–4.0 MVwhen filled with a
solution for If recordings containing (mM): KCl 120, TEA-Cl
10, Na2GTP 0.4, Na2ATP 5, MgCl2 2, EGTA acid 11, CaCl2
5 and HEPES 5; pH 7.2. Cells were bathed in modified Tyrode
solution containing (mM): NaCl 140, KCl 25,MgCl2 1.2, CaCl2
1.8, glucose 10, NiCl2 2, BaCl2 2, 4-aminopyridine 0.5 and
HEPES 5; pH 7.4. Series resistances were automatically com-
pensated by 70%. I–V relationships were recorded by 1.5 s
voltage steps ranging from 220 to 2120 mV in 20 mV incre-
ments, recorded from a holding potential of 230 mV with a
sweep time interval of 10 s. Tail currents were elicited by a
300 ms step to 2110 mV.
For action potential measurements, HL-1 cells were grown to
100% confluency, and action potentials were measured in the
current clampmodewithout electrical stimulation.Pipetteshada
resistance between 2.5 and 4.0 MV, when filled with a solution
containing (mM): KCl 60, K-glutamate 65, Na2GTP 0.2, K2ATP 3,
MgCl2 2, EGTA 5, and HEPES 5; pH 7.2. Whole-cell measure-
ments were obtained at room temperature in a bath solution
containing (mM): NaCl 135, KCl 5, MgCl2 1, NaH2PO4 0.33,
glucose 10, Na-pyruvate 2, CaCl2 1 and HEPES 10; pH 7.4.
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Slice patch-clamp experiments of neurons of the
Pir and the thalamus
Animalswere euthanized under isoflurane anesthesia, and brain
tissue was rapidly removed from the skull. Thalamic coronal
slices (250mm)were prepared fromVAPB2/2 andC57Bl/6N tac
mice (p90-p120) on ice-cold oxygenated (O2) saline solution,
containing (mM): sucrose 200, PIPES 20, KCl 2.5, NaH2PO4 1.25,
MgSO410,CaCl2 0.5, dextrose10;pH7.35. Sliceswere transferred
to a chamber with an artificial cerebrospinal fluid containing
(mM): NaCl 125, KCl 2.5, NaH2PO4 1.25, NaHCO3 24, MgSO4 2,
CaCl2 2, dextrose 10; and kept for 30 min at the temperature of
30–32°C and further at room temperature until the recording
started. pH was adjusted to 7.35 by constant aerating with
carbogen (95%O2and5%CO2). Ihwas recorded in thewhole-cell
mode from thalamocortical neurons of the ventrobasal thalamic
complex and pyramidal neurons of the piriform cortex (Pir).
Slices were transferred to a recording chamber with an external
solution (bath solution) containing (mM): NaCl 120, KCl 2.5,
NaH2PO4 1.25, HEPES 30, MgSO4 2, CaCl2 2, dextrose 10; pH
7.25. Recordings were performed at 30 6 1°C. Patch pipettes
were pulled from borosilicate glass (GC150T-10; Clark Electro-
medical Instruments, Edenbridge, United Kingdom) and had
resistances of 3–5 MV. The pipette solution contained (mM): K-
gluconate 95, K3-citrate 20, NaCl 10, HEPES 10, MgCl2 1,
CaCl2 0.5, BAPTA 3, MgATP 3, Na2GTP 0.5; pH 7.25 and
295 mOsm/kg. All recordings were made from the soma of the
neurons using an EPC10 amplifier (Heka Electronik). The access
resistance was in a range of 5–25 MV and was monitored
throughout the whole experiment. Cells with access resistance
.25MVwerediscarded. Series resistance compensationof.30%
was applied. Voltage-clamp experiments were controlled by the
software Pulse or PatchMaster (Heka Electronik). Measurements
were corrected for a liquid junction potential of 10 mV. The pro-
tocol used for assessment of Ih current is as previously described
(5). Briefly, Ih current was measured by hyperpolarizing steps of
210mV increments fromaholding potential of240 to2130mV.
Immunohistochemistry of HCN channels in the Pir
Twenty- to thirty-day-old C57BL/6NTac mice were trans-
cardially perfused with 4% paraformaldehyde. Brains were re-
movedandpostfixed for 2h in 4%paraformaldehydeand later in
30% sucrose for 48 h. Free-floating coronal sections (40mm)were
cut, and slices were collected in PBS. Sections were washed 3
times for 10 min in PBS and preincubated for 20 min in PBS
containing0.3%Triton-X100. Sliceswere then incubated for 2h in
6% normal goat serum in PBS/Triton-X100 0.3%. Slices were
incubatedwithprimary antibodies: rabbit (rb)-anti-HCN1 (APC-
056, 1:200), rb-anti-HCN2 (APC-030, 1:200), rb-anti-HCN4 (APC-
052, 1:200) (polyclonal rabbit-antibodies; Alomone Labs), and
guinea pig–anti-Map2 (188004, 1:100; Synaptic Systems,
Go¨ttingen, Germany) for 48 h at 4°C. After incubation with the
primary antibody, sliceswerewashed 3 times for 10min in PBS
and thereafter transferred to the secondary antibody solution
(Alexa Fluor 568 goat anti–guinea pig IgG, ab175714, 1:1000
andAlexa Fluor 488 goat anti-rb-IgG, ab150113, 1:1000) for 1 h,
washed 3 times thereafter for 10 min and mounted with a
mounting medium (Vectashield with DAPI; Vector Laborato-
ries, Burlingame, CA, USA) for confocal microscopy.
Patch-clamp recordings of INa and ICa in induced
pluripotent stem cell–derived cardiomyocytes
Whole-cell patch-clamp experiments for measurement of Ca2+
and Na+ currents were performed in murine-induced pluripo-
tent stem cell–derived cardiomyocytes (iPSC-CMs; commer-
cially available from Axiogenesis AG, Cologne, Germany; http://
axiogenesis.com/). Cells were seeded in 35 mm glass bottom dishes
(MatTek Corp., Ashland, MA, USA) coated with laminin and fi-
bronectinatadensityof23104cellsperdish.Cellswere incubated
at 5% CO2 and 37°C with CorAt media. Cells were transfected
with pEGFP empty vector (200 ng) either with pcDNA3.1(+)
vector (1 mg) as control or with VAPB pcDNA3.1(+) (1 mg) using
Lipofectamine 3000 (Thermo Fisher Scientific) following manual
instructions. Currents were measured 48–72 h after transfection
with glass electrodes (1.5–5 MV) filled with intracellular solution
containing (mM): NaCl 8, CsAsp 120, TEA-Cl 20, MgCl2 5.9,
HEPES 20 and K2ATP 5, pH 7.2. An EPC-10 amplifier (HEKA
Electronik) and the Fitmaster program (Heka Electronik) were
used for data acquisition. For measurements of the Ca2+ currents
(ICa), cellswerekept innormal tyrodesolution (mM:NaCl140,KCl
5.4, MgCl2 1.1, HEPES 5, glucose 10, CaCl2 1.8, pH 7.4) supple-
mented with CsCl (5 mM). Whole-cell currents were recorded
from a holding potential of 280 mV, using a 500 ms voltage
ramp from 280 to 240 mV to inactivate sodium currents be-
fore I–V measurements. Starting from a test potential of
240 mV, cells were clamped to different voltages in 400 ms steps
ranging from250 to 40mV in 10mV increments. Sodiumcurrents
(INa) were elicited in a bath solution containing (mM): NaCl 20,
NMDG120,KCl4,MgCl21,CaCl21.8,HEPES5,glucose10,pH7.4,
supplemented with 5 mM nifedipine. Whole-cell currents were
recorded from a holding potential of280 mV followed by 100 ms
voltage steps from280 mV to 40 mV in 5 mV increments.
Patch-clamp recordings of Cav1.3 in HEK293 cells
HEK293 cells were cultured in 25 cm2 flasks at 37°C and 5%CO2
in DMEM (Thermo Fisher Scientific) supplemented with 10%
FCS and 1% penicillin/streptomycin solution (Thermo Fisher
Scientific). At a confluency of 60–70%, cells were transiently
transfected with cDNA encoding Cav1.3 a1-subunits (human,
6 mg/flask) together with auxiliary b2b (human, 3 mg/flask) and
a2d1-subunits (human, 3 mg/flask), EGFP (0.5 mg/flask), and
emptyvector (pcDNA3.1(+), 3mg/flask)orVAPB(human, 3mg/
flask) using JetPrime (Peqlab). Cells were subsequently kept at
30°C and 5%CO2. Forty-eight hours after transfection, cells were
detached by using 0.05% trypsin and transferred to 35-mm Petri
dishes for electrophysiological recordings. Whole-cell patch-
clamp recordings were performed at room temperature with an
EPC10 amplifier (Heka Electronik) using electrodes pulled from
borosilicate capillaries with a resistance of 2–5 MV. Series re-
sistance was compensated by 50%. The extracellular solution
contained 110 mM NaCl, 20 mM CsCl, 10 mM BaCl2, 10 mM
HEPES, 1 mMMgCl2, and 10 mM glucose (pH 7.4). The pipette
internal solution contained 130 mM KCl, 10 mM NaCl, 0.5 mM
MgCl2, 1 mM EGTA, and 5 mM HEPES (pH 7.3). I–V relation-
ships were obtained by applying a 300 ms long square pulse
protocol to various test potentials starting from a holding po-
tential of280 mV.
Cell culture
HEK293 and HeLa cells were obtained from Sigma-Aldrich and
mouse iPSC-CMs from Axiogenesis, which were not authenti-
cated again after commercial purchase. HL-1 cells were pre-
viously obtained by Prof. W. Claycomb (Louisiana State
University Health Sciences Center, New Orleans, LA, USA) and
authenticated by their electrophysiological properties (21). All
cells were probed for mycoplasma contamination.
Quantification and statistical analysis
Statistics were performed as previously described (29). Briefly,
every dataset for wild-type and each mutant and for every
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current/kinetical feature analyzed were tested with a
Shapiro-Wilk test for normality. Equality of variances was
tested by using either a parametric or nonparametric Levene’s
test. In case of similar variances, significance was probed by
using either a paired or unpaired Student’s t test; for non-
normally distributed data, a nonparametric Mann-Whitney U
test and a Wilcoxon signed-rank test for paired analyses was
used, respectively. If the variances of the groupswere different,
significance was probed by using Welch’s t test; for non-
normally distributed data, Mood’s median test was used. Ex-
periments were nonrandomized and nonblinded, and no
prespecified sample size was estimated.
For inclusion/exclusion criteria, only dead embryonic zebra-
fish were excluded from the statistical analyses. For experiments
using VAPB2/2 mice, estimated differences were based on pre-
vious data and calculations of sample size assuming 1 – b = 0.80
and a = 0.05. To detect changes in ECG recordings, at least 8 ani-
mals per genotypewere used to ensure adequate power to detect
20–30% change. All alive and healthy-looking littermate animals
were examined. ECG recordings of all examined mice was high
enough in quality for analyzing heart rate, PQ interval, QT in-
terval, and duration of QRS complex following pre-established
criteria.T-wavemorphologyanalysis of 3micehad tobeexcluded
because signals were divergent from pre-established criteria. The
order of taking ECG recordings was randomized to consecutive
order following cage numbers,whichweremarkedby the animal
facility. The investigators performing and analyzing the ECGs
were blinded to the genotype.
Ethical approval
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals (National Institutes of Health, Bethesda, MD,
USA). All experimental procedureswere performed in accordance
with the principles approved by local authorities (Landesamt fu¨r
Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen,
Germany; 84-02.04.2015.A574, 84-02.05.50.15.026 and 887-50 10
37 09.125) or the United Kingdom Home Office (30/2967). Efforts
were made to minimize the number of animals and the degree of
discomfort to animals used in this study.
RESULTS
VAPB selectively increases HCN1 and HCN2
pacemaker currents
Usinga split-ubiquitinY2H(30) screenwith the full-length
HCN2 channel as a bait to search for plasma membrane–
bound channel modulators, VAPB was identified from a
human adult brain cDNA library as a potential HCN2
interacting partner. From 458 clones that grew under
dropout conditions, 35 clones contained VAPB. In con-
trast, VAPA, the closest relative of VAPB, was not fished
from the human brain cDNA library. Y2H direct-
interaction assays confirmed an interaction of VAPB
with HCN2 but not HCN4 (Fig. 1A). VAP proteins are
anchored with a C-terminal TM domain in the cell mem-
brane, contain a conservedN-terminalmajor spermregion
(MSP) andanamphipathic coiled-coil domain (CC),which
is a common motif in t-SNAREs (31) (Fig. 1B). The VAPB
fragments identified through the Y2H screen include the
TMdomain and parts of the CCdomains but not theMSP
domain (Supplemental Fig. 1). GST pull-down experi-
ments confirmed an interaction of HCN2 with VAPB
(Fig. 1C) but also the close family member VAPA and
theVAP-interacting partners VAMP1 andVAMP2 (Fig.
1D). Using HCN2 transfected HeLa cells, GSTVAPA
pulled down HCN2 together with endogenously
expressed VAPB, suggesting that HCN2 channels
might be in a complex with VAPA and VAPB (Fig. 1E).
VAPB and VAPA both directly interact with in vitro
translated HCN2, although the physical interaction
with VAPA seems to be more efficient (Fig. 1F). Pull-
down experiments with in vitro translated HCN2 also
confirmed a direct interaction with VAMPs. Most im-
portantly, both GSTVAPA and GSTVAPB pulled down
HCN2 from rat brain protein lysates (Fig. 1G).
The coexpression ofHCN2with low amounts of VAPB
in Xenopus oocytes strongly increased current amplitudes
(Fig. 1H, I). HCN1 current amplitudeswere also increased
(Fig. 1J), whereas HCN4 was not modulated, consistent
with our interaction analyses (Fig. 1A, J). None of the other
tested potassium channels were influenced by VAPB, re-
vealing a selectivity for HCN1 and HCN2 channels (Fig.
1K). To further support this observation, we performed
patch-clamp experiments of mouse iPSC-CMs transfected
withVAPB toprobe for effects ofVAPBon cardiac sodium
and calcium channels. VAPB transfection did not alter
inward sodium (INa) or calcium (ICa) currents (Supple-
mentalFig. 2A–FandMaterials andMethods). In addition,
because these iPSC-CMs reflect ventricular cardiomyocytes
rather than sino-atrial pacemaker cells, we also excluded
that VAPBmodulates Cav1.3, a channel highly relevant for
sino-atrial pacemaking (Supplemental Fig. 2G–I). The VAP
family contains an alternative spliced isoform, VAPC, lack-
ing the CC and the TM domains (17, 32); whereas VAPA
also mildly increases the HCN2 current amplitudes, VAPC
has nomodulatory effect (Fig. 1L and Supplemental Fig. 3).
Strikingly, coexpressing HCN2 together with VAPA and
VAPB led toa similar and slightlymorepronouncedcurrent
increase (Fig. 1M), comparedwithVAPBcoexpressedalone.
Although the current increase was not significantly larger,
the effect was more robust (HCN2 + VAPB, P , 0.01, vs.
HCN2 + VAPA/VAPB, P, 0.001).
VAPB did not alter the voltage dependence of HCN2
activation (Supplemental Fig. 4A) or the activation kinetics
(Supplemental Fig. 4B); a similar lack of effects was ob-
served for VAPA and VAPC (Supplemental Fig. 3). Be-
cause the effects of VAPB on the voltage-dependence of
activation might be missed due to the high cAMP levels
intrinsic to oocytes, we performed inside-out macropatch-
clamp recordings from oocytes to directly control intra-
cellular cAMP concentrations. However, also in inside-out
patches and in absence of intracellular cAMP, VAPB did
not influence the voltage dependence of activation (Fig.
1N–Q). In addition, application of 100 mM cAMP maxi-
mally shifted the voltage dependence of activation in a
similar manner, as for HCN2 alone, indicating that there is
noeffectofVAPBonthecAMPmodulationof thechannels.
We next investigated the mechanism for the increased
HCN2 current amplitudes. The current amplitudes
of HCN2, now harboring an extracellular HA-epitope
(HCN2HAEx), was increased, similar as described for the
untagged protein (Fig. 1R). The surface expression in the
same oocytes, probed with a chemiluminescence-assay
6164 Vol. 32 November 2018 SILBERNAGEL ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by Univ of Birmingham Barnes Medical Library (147.188.108.18) on August 27, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 6159-6173.
(ELISA) exclusively detecting channels at the plasma
membrane, revealed that the increased current amplitudes
are mainly caused by an increased surface expression of
the channels (Fig. 1R, S).
ThepreviouslydescribedVAPBP56Smutation located in
the MSP domain causes amyotrophic lateral sclerosis
(ALS) 8 and late-onset spinal muscular atrophy (33).
Coexpression of VAPBP56S with HCN2 revealed that the
ALS-causingmutation lost its ability to increase theHCN2
current amplitudes (Fig. 1T).
Domains mediating the interaction of VAPB
with HCN2
A split-ubiquitin Y2Hdirect-interaction assay introducing
different premature stop codons in HCN2 revealed that
the CNBD and the entire C terminus are dispensable for
the interaction with VAPB and that the N terminus of
HCN2 together with the S1 segment are sufficient
for the interaction (Fig. 2A, B and Supplemental Fig.
5). These data are supported by functional studies
(Fig. 2C) in which VAPB still increased the current am-
plitudes of HCN2 channels that lack the entire C terminus
(HCN2F486*). In contrast, current amplitudes of HCN2
channels with an N-terminal deletion (NTKHCN2) (34)
were no longer modulated by VAPB (Fig. 2D). Consis-
tently, the NTKHCN2HAEx current amplitude (Fig. 2E) and
surface expression (Fig. 2F) were not altered by VAPB.
Similar effects were obtained replacing the N terminus of
HCN2 by that of HCN4 (HCN4-NHCN2), which also
resulted in a loss of VAPB modulation (Fig. 2G).
We next probed which parts of VAPB mediate the
functional effects on HCN2. Surprisingly, the TM segment
of VAPB alone (TMVAPB) is sufficient to increase HCN2
Figure 1. VAPB selectively increases HCN1 and HCN2 currents. A) Y2H direct interaction assay. Transformation control (-LW),
leucine, and tryptophan dropout. Interaction read-out (-LWHA), additional dropout of histidine and adenine. pAL-Alg5, positive
control. pPR3-N, negative control. B) Topology of VAPB. C) GSTVAPB pull-down of HCN2EGFP using transfected HeLa cells. D)
GSTVAPA, GSTVAMP1, or GSTVAMP2 pull-down of HCN2EGFP using transfected HeLa cells. E) GSTVAPA pull-down of HCN2 and
endogenous VAPB, using HCN2EGFP transfected HeLa cells. F) Pull-down of in vitro translated HCN2 (untagged). G) Pull-down
of HCN2 from rat brain lysates. H , I) Representative currents (H) of HCN2 expressed in oocytes alone or with VAPB and the
relative current amplitudes (I) analyzed over 3 d. J ) Relative currents of HCN1, HCN2, and HCN4 alone or coexpressed with
VAPB. K , L) Relative currents of different potassium channels (K) coexpressed with VAPB and of HCN2 (L) coexpressed with
VAPA, VAPB, or VAPC. M) Relative currents of HCN2 coexpressed with a mixture of VAPA/B (1:1). N) Representative
macropatch recordings in different conﬁgurations: on cell (o.c.), inside-out after patch excision (i.o.), and after application of
100 mM cAMP (i.o.+100 mM cAMP). O, P) Activation curves for HCN2 alone (n = 6) (O), recorded as in N , or after coexpression
with VAPB (n = 8) (P). Q) V1/2 values for HCN2 expressed alone or with VAPB in different patch modes. R) Relative currents of
HCN2HAEx alone or with VAPB. S) Relative surface expression of HCN2
HA
Ex expressed alone or with VAPB, analyzed as relative
light units (RLUs). T) Relative currents of HCN2 expressed alone or with VAPB or VAPBP56S. All data are presented as means 6
SEM. The number of cells (n) is indicated in the bar graphs. N.s., not signiﬁcant. *P , 0.05, **P , 0.01, ***P , 0.001 [unpaired
Student’s t test (H, K, L, O–S) or Mann-Whitney U test (I, J, M, N, T)].
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currents (Fig. 2H), whereas the MSP domain alone or in
combination with the CC domain (MSP+CCVAPB) is in-
effective. These data are consistent with the lack of HCN2
modulation by VAPC, which lacks the TM domain (17).
Confirming the role of the TM segment for channel mod-
ulation, the HCN2HAEx current amplitudes (Fig. 2I) and
surface expression (Fig. 2J)were also increasedbyTMVAPB.
VAPB determines surface expression and
dendritic localization of HCN2
Cotransfection of N-terminally tagged HCN2HAEx
(EGFPHCN2HAEx) with VAPB or TM
VAPB resulted in in-
creased fluorescence at the plasma membrane (Fig. 3A).
Untagged VAPB was used for these recordings because
fluorescentprotein tags reportedly cause adimerizationof
VAPB (35, 36). The increased surface expression was
quantified detectingHCN2channels at the cellmembrane
by using nonpermeabilized, fixed cells and an ELISA as-
say, recognizing the extracellular HA-epitope of the
EGFPHCN2 HAEx construct. Consistent with the data from
the oocyte expression system (also Fig. 2F, J and Supple-
mental Fig. 1), an increased surface expression of HCN2
wasobserved in thepresence ofVAPBorTMVAPB (Fig. 3B,
C).We thenprobedwhether the effects ofVAPBonHCN2
surface expression are caused by alterations in channel
endocytosis. We therefore used either dynasore or the C
terminus of the adaptor protein 180 (AP180C), a construct
that blocks clathrin-mediated endocytosis (20, 37). Here,
despite inhibiting endocytosis by dynasore or AP180C,
VAPB increased theHCN2 surface expressionwith a similar
efficiency (Supplemental Fig. 6A–C). Taken together, these
data support the theory that enhanced surface expression of
HCN2 is most likely caused by a more efficient forward
transport of the channel to the plasma membrane. Because
HCN2 currents and surface expression are also increased by
aminimalVAPBprotein (TMVAPB),withasingleTMdomain
(Figs. 2H–J and3A,C), themost straightforward explanation
is that VAPB may be part of the native HCN channel com-
plex which is more efficiently transported to the membrane.
We next analyzed the endogenous HCN2 expression
in primary cortical neurons after transfection with HA-
tagged VAPB (HAVAPB) (Fig. 3D). Here, HCN2 and
transfected HAVAPB strongly colocalized in the den-
drites and the soma of the neurons (merge to white). In
contrast, the transfected ALS8 mutation HAVAPBP56S
aggregates in the soma, consistent with previous stud-
ies (35) (Fig. 3E). Most importantly, HCN2 fluorescence is
now primarily located in the soma, and a loss of distri-
bution into the dendrites can be observed, although the
dendrites of the neurons are still intact, as visible from the
MAP2 staining of HAVAPBP56S transfected neurons.
Figure 2. Domains mediating the interaction of VAPB with HCN2. A) Schematic illustration of a HCN subunit. The CNBD and
some of the truncation constructs studied are indicated. B) All truncation constructs exhibited a positive interaction, evident
from growth on -LWHA dropout medium. C ) Representative current traces and the relative currents for different
C-terminal deletions expressed alone or with VAPB. D) Representative current traces and the relative current amplitudes
for the N-terminal truncated NTKHCN2 expressed alone or with VAPB. E) Relative current amplitudes of NTKHCN2HAEx
(extracellular HA-tag) expressed alone or with VAPB. F) Relative surface expression of NTKHCN2HAEx expressed alone or with
VAPB analyzed as relative light units (RLUs). G) Schematic illustration, representative traces, and currents of a HCN2 channel
chimera with the N terminus of HCN4 (HCN4-NHCN2) expressed alone or with VAPB. H) Relative currents of HCN2 expressed
alone or coexpressed with VAPB (1.7 6 0.1), TMVAPB (1.6 6 0.2), the MSP domain (MSPVAPB), the MSP with half of the CC
domain (MSP-CC0.5
VAPB), or with the complete CC domain (MSP-CCVAPB). I, J ) Relative current amplitudes of HCN2HAEx
expressed alone or with TMVAPB (1.3 6 0.1) (I) and the respective changes in the relative surface membrane expression
analyzed as RLUs, using a single cell chemiluminescence assay (TMVAPB 1.8 6 0.2) (J ). All data are presented as means 6 SEM.
The number of experiments (n) is indicated in the respective bar graphs. N.s., not signiﬁcant. *P , 0.05, **P , 0.01, ***P ,
0.001 [unpaired Student’s t test (E), Mann-Whitney U test (C, D, F–H, J ), or Welch’s t test (I)].
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Codistribution of VAPs with HCN2 and
contribution to thalamicIh
We next investigated the distribution of VAPB, VAPA,
and HCN2 mRNAs in mouse brain and spinal cord by
using ISH experiments (Fig. 4A–E). In general, VAPB hy-
bridization signals were weaker than those for VAPA.
Highest VAPBmRNA levels were detected in the Pir (Fig.
4A), the CA3 region of the hippocampus (Fig. 4B), the
hypothalamic arcuate and ventromedial nucleus, and in
medialhabenulae (Fig. 4B,C).Anoverlappingdistribution
of VAPB and HCN2 was noted in many brain regions,
particularly evident in the reticular thalamic nucleus and
globus pallidus (Fig. 4C). Hybridization signals for all 3
transcripts were observed in the subthalamic nucleus, the
ventrobasal thalamic nucleus, the habenulae, and also the
spinal cord (Fig. 4E).
Although the distribution of VAPB and HCN2
mRNA expression was very similar in all regions ex-
amined (Fig. 4A–E), the VAPA mRNA expression
pattern was only partially overlapping in some brain
regions. For example, Purkinje cells of the cerebellar
cortex express relatively high mRNA levels for VAPA
but only very low levels for HCN2 and VAPB (Fig.
4D). Most importantly, the observed coexpression of
VAPBwith HCN2 in the aforementioned neurons is in
perfect agreement with the functional interaction we
describe.
Consistent with a thalamic coexpression of HCN2
and VAPB and the role of VAPB to increase macro-
scopic HCN2 and HCN1 currents, patch-clamp ex-
periments in neurons of the ventrobasal thalamus of
VAPB2/2 mice (27) revealed significantly reduced Ih
current amplitudes (Fig. 4F, G). Although Ih current
Figure 3. VAPB determines surface expression and dendritic localization of HCN2. A) Live cell imaging of HeLa cells transfected
with an N-terminally EGFP-tagged HCN2 carrying an extracellular HA-epitope (EGFPHCN2HAEx) alone or cotransfected with
VAPB or the TM segment of VAPB (TMVAPB). B) Chemiluminescence assays of ﬁxed non-permeabilized HeLa cells, analyzing the
surface expression as relative light units (RLUs) for EGFPHCN2HAEx alone and after cotransfection with VAPB (1.6 6 0.1). Upper
inset illustrates a representative control Western blot showing an unaltered HCN2 protein expression. C) Chemiluminescence
surface expression assay as in B, but using TMVAPB (1.66 0.1). D) Immunocytochemistry of HAVAPB transfected cortical neurons.
Endogenous HCN2 (green) is colocalizing (white) with HAVAPB (magenta) in the soma and dendrites. Anti–MAP2-staining
illustrating an intact neuronal network and dendrites (blue). E) Immunocytochemistry experiment as in D, but transfecting the
ALS8 mutation HAVAPBP56S (magenta), leading to an aggregation of VAPBP56S in the soma of the neurons. Also, HCN2
ﬂuorescence (green) was focused in the soma and dendritic localization was lost, despite an intact neuronal network (a-MAP2,
blue). Scale bars, 20 mm (A, D, E). All data are presented as means 6 SEM. The number of experiments (n) is indicated in the
respective bar graphs. **P , 0.01 (unpaired Student’s t test).
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amplitudes were reduced, no major effects on the
voltage dependence of activation were observed (Fig.
4H). In addition, we performed patch-clamp experi-
ments of neurons of the Pir that have, in contrast to the
ventrobasal thalamus, a pronounced expression of
HCN1 and reduced HCN4 levels (Supplemental
Fig. 7A–C and Materials and Methods). We found
only a minor reduction of Ih current amplitudes, and
the voltage dependence was not significantly altered
(Supplemental Fig. 7D–G). However, the speed of
activation was slowed (Supplemental Fig. 7H), which
is consistent with a reduced relative contribution of
HCN1 channel to native Ih currents in the Pir. The fact
that kinetics change while the overall Ih amplitudes
largely remain unaltered indicate that there might
be up-regulation of other channels or subunits after
VAPB knock-out.
Bradycardia in knock-down zebrafish embryos
and VAPB2/2 mice
ISH and RT-PCR experiments using zebrafish hearts at 72
hpf revealed a cardiac expressionof bothVAPAandVAPB
in the embryonic heart (not illustrated). Using whole-
heart immunostainings, VAPB expression was evident
throughout the atrium and ventricle of the embryonic
zebrafish heart (Supplemental Fig. 8A–B). Subsequently,
to elucidate the functional role of VAPs for cardiac pace-
making in vivo, we inactivated either VAPB or VAPA us-
ingMO, targeting the translation initiation site of zebrafish
VAPA (MOVAPA) or VAPB (MOVAPB) (Fig. 5A–F).
Knock-down of either VAPA or VAPB did not cause
structural heart defects (data not shown). For MOVAPB, a
mild and for MOVAPA a pronounced pericardial edema
was observed (Fig. 5A). Moreover, a bradycardia was
Figure 4. Codistribution of VAPs with HCN2 and contribution to thalamic Ih. A–E), Distribution of HCN2, VAPB, and VAPA
mRNA in mouse brain and spinal cord. ISH analysis of HCN2, VAPB, and VAPA using DIG-labeled riboprobes, revealing mRNA
expression of VAPB in cortical areas (A), hippocampus (B), thalamus (C), cerebellum (D) (arrows point to interneurons in the
granular layer), and spinal cord (E). Note the overlapping distribution of VAPB with HCN2 and VAPA mRNA. Am, amygdala;
CA, cornu ammonis; DG, dentate gyrus; DH, dorsal horn; gcl, granule cell layer; Hb, habenulae; ic, internal capsule; LG, lateral
geniculate ncl.; m, molecular cell layer; pcl, Purkinje cell layer; RTh, reticular thalamic ncl.; Sth, subthalamic ncl.; VB, ventrobasal
thalamus; Th, thalamus; VH, ventral horn. F) Representative current traces elicited in slice patch-clamp experiments of the
ventrobasal thalamus (VB) of wild-type animals (control) and VAPB2/2 mice. G) The Ih current was signiﬁcantly reduced in
VAPB2/2 mice (15.4 6 1.1 pA/pF) compared with control animals (22.2 6 2.3 pA/pF). H) Average activation curves of the VB
Ih current for control and VAPB
2/2mice. V1/2 of activation for control (291.66 1.3 mV, n = 8) and VAPB
2/2 (287.56 1.2 mV,
n = 7). Scale bars: 500 mm (A–C, E), 100 mm (D). All data are presented as means 6 SEM. The number of experiments (n) is
indicated in the respective bar graphs. *P , 0.05 (unpaired Student’s t test).
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evident in both types of morphant zebrafish embryos
(Fig. 5B), with 101 6 12 beats/min for VAPA morphants
and 125 6 10 beats/min for MOVAPB-injected embryos,
compared with control-injected embryos with 153 6
5 beats/min. As proof for the specificity of the knock-
down, theheart rateofMOVAPB-injectedembryoscouldbe
rescued by the concomitant injection of either VAPA or
VAPB cRNA (Supplemental Fig. 8C, D). It is noteworthy
that the injectionof cRNAfor thehumanVAPBP56Smutant
into zebrafish embryos caused no significant reduction in
the heart rate (Supplemental Fig. 8E), indicating that the
construct does not act in a dominant-negative manner on
zebrafish If current components. Although heart rate was
significantly reduced inVAPAandVAPBmorphants, both
cardiac chambers, atrium and ventricle, contracted regu-
larly and sequentially as inwild-types,whereby each atrial
contraction was followed by a ventricular contraction, in-
dicating unaffected atrio-ventricular conduction.
Bradycardia was evenmore severe when VAPA and
VAPB were simultaneously inactivated (MOVAPA/B)
and VAPA/VAPB morphants had severely reduced
heart rates (55 6 41 beats/min). In contrast to the
VAPA or VAPBmorphants, the double knock-down of
VAPA and VAPB led to a broad heart rate variability
(Fig. 5D, E) and, in 20% of all morphant embryos, to
severe heart rhythm disturbances (n = 20) (Fig. 5F). To
evaluate if abnormal cardiac excitation propagation
or excitation-contraction-coupling account for the
bradycardia and heart rhythm disturbance, we moni-
tored free cytosolic myocardial calcium and cardiac
contraction simultaneously. In 80% of VAPA/VAPB
morphants (n = 20), cardiac excitation starts in the
atrium and propagates from the atrium toward the
ventricle, evident as each atrial calcium wave is fol-
lowed by a calcium wave through the ventricle. In
addition, each calciumwave is accompanied by cardiac
chamber contraction (not illustrated), indicating that
cardiac excitation in VAPA/VAPB morphants is ap-
propriately initiated in the atrium but with a reduced
frequency compared with controls. As described ear-
lier, in 20% of all MOVAPA/B-injected embryos, con-
duction abnormalities were observed (n = 20). We
found atrio-ventricular blocks, in which not every atrial
excitation causes ventricular excitation, as evident from Fig.
5F illustrating a 2:1 atrio-ventricular block. The excitation-
contraction coupling of VAPA/VAPB morphants was
Figure 5. Bradycardia in knock-down zebraﬁsh embryos and VAPB2/2 mice. A) Zebraﬁsh embryos at 72 hpf. Control-injected
and MO-injected embryos against VAPA (MOVAPA) or VAPB (MOVAPB) exhibit no signiﬁcant abnormalities (left), particularly
no structural heart defects (right). Note a light cardiac edema in MOVAPB and a strong edema in MOVAPA. B) Heart rate in beats
per minute (bpm) of control and MOVAPA, MOVAPB, or MOVAPA/B injected zebraﬁsh embryos at 72 hpf. C) Representative
examples of calcium transients (relative ﬂuorescence intensity) in the cardiac atrium (black) and cardiac ventricle (gray) of
control-injected zebraﬁsh at 72 hpf, displaying a regular atrio-ventricular propagation of excitation from atrium to ventricle in a
1:1-ratio. D, E), Representative calcium transients recorded in MOVAPA/B double knock-down morphants, illustrating strongly
reduced heart rates with variable frequency. F) Representative example of atrial and ventricular calcium measurements from a
MOVAPA/B morphant with a 2:1 atrio-ventricular block, in which only every second atrial excitation leads to a ventricular
excitation. Data were obtained from 3 independent batches of injections (A–F). G) Heart rate in beats per minute (bpm) of
VAPB2/2 mice compared with wild-type littermates (control), analyzed by using tail-cuff measurements. H) Representative
surface ECG recordings of VAPB2/2 mice and their wild-type littermates (control). ECGs of VAPB2/2 mice show bradycardia
and an increased T-wave amplitude. I–N) Analyses of the ECG parameters of VAPB2/2 mice. I) Heart rate in beats per minute
(bpm). J ) PQ interval (PQ) duration. K) QRS complex (QRS) duration. L) Frequency corrected QT interval (QTc). M)
Frequency-corrected Tpeak to Tend duration (Tp-Tec). N) T-wave amplitude (JTp). Scale bars: 500 mm (A); 500 ms (C–F), and
100 ms (H). All data are presented as means6 SEM. The number of animals (n) is indicated in the respective bar graphs. N.s., not
signiﬁcant. *P , 0.05, **P , 0.01, ***P , 0.001 [Student’s t test (G, H, J–N) or Welch’s t test (B, I)].
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intact, indicating that knock-down of VAPA/VAPB only
impairs the initiationofexcitation in theatriumandtheatrio-
ventricular conduction, which is likely to correlate to a QT
time prolongation in mice.
Tail-cuff measurements of VAPB2/2 mice detected a
prominent heart rate reduction (Fig. 5G) that did not, how-
ever, result in altered blood pressure (Supplemental Fig. 9).
Surface ECG recordings of VAPB2/2mice (Fig. 5H–N and
Supplemental Figs. 10 and 11) revealed a sino-atrial brady-
cardia (Fig. 5H, I), as heart rates were reduced while the
duration of the PQ interval, corresponding to atrio-
ventricular conduction, was unchanged (Fig. 5J, K). How-
ever, the QTc interval (Fig. 5L) was prolonged by ;8%. In
addition, the Tpeak-Tend (Tp-Tec) interval (Fig. 5M) was pro-
longed and the JT-wave amplitude was increased (Fig. 5N
and Supplemental Fig. 11), effects that were also observed
for mice with genetically impaired HCN channels (38).
VAPB modulates If of spontaneously beating
cardiac HL-1 cells
We next studied the effects of VAPB in HL-1 cells, a
spontaneouslybeating sino-atrial node-like cardiomyocyte
cell line (39). HL-1 cells endogenously express VAPB
(Fig. 6A), which was efficiently diminished by short
hairpin RNA (shRNA)-mediated knock-down (Fig. 6B).
Overexpression of VAPB in HL-1 cells accelerated spon-
taneousbeating rates (Fig. 6E), consistentwith increased If
amplitudes. As previously reported, not all HL-1 cells
express macroscopic If currents (28). However, we found
If-containing cells 1.5-fold more often when HL-1 cells
were transfected with VAPB (Fig. 6D). Strikingly, the ki-
netics of channel activationwas acceleratedbyVAPB (Fig.
6C, F), and the voltage dependence of If was shifted by
10 mV (Fig. 6G, H). This effect can be explained by in-
creased HCN1 and HCN2 current amplitudes and thus a
decreased relative contribution of HCN4 to If in this cell
line. Conversely, shRNA-mediatedknock-downofVAPB
significantly reduced the spontaneous action potential
frequency (Fig. 6I, K) by a prolongation of the diastolic
depolarization phase (Fig. 6I, J). Norepinephrine treat-
ment of HL-1 cells increased the beating frequency and,
also under these conditions, VAPB knock-down strongly
reduced the beating frequency (Supplemental Fig. 12).
Strikingly, VAPB knock-downhad the opposite effects on
current kinetics and voltage dependence, as VAPB over-
expression. VAPB knock-down slowed the activation
time constants (Fig. 6L) and led to more hyperpolarized
V1/2 values (29 mV) (Fig. 6M, N). These in vitro data
confirm that VAPB serves to increase macroscopic If cur-
rents in sino-atrial cells, providing an explanation for the
sino-atrial bradycardia observed in VAPB2/2mice.
Figure 6. VAPB modulates If of spontaneously beating cardiac HL-1 cells. A) Immunocytochemistry of VAPB in HL-1 cells. Scale
bar, 20 mm B) Western blot illustrating the knock-down of VAPB expression in HL-1 cells by shRNA transfection. Control, HL-1
cells transfected with scrambled shRNA. C) Representative If currents of HL-1 cells under control conditions and after VAPB
transfection. D) Percentage of HL-1 cells containing If under control conditions (38%) and after VAPB transfection (58%). E)
Beating frequency under control conditions (158 6 4) and after VAPB transfection (179 6 4), analyzed by optical counting of
contractions in original Claycomb medium containing norepinephrine (60). F) Accelerated activation kinetics of VAPB-
transfected HL-1 cells (n = 9–10). G) Activation curves of HL-1 cells under control conditions (n = 10) and after VAPB
transfection (n = 11). H) Positive shift in the V1/2 of activation of If recorded in VAPB transfected HL-1 cells. Control (scrambled
shRNA),290.36 3.4 mV (n = 10); VAPB transfected, 279.66 2.7 mV (n = 11). I) Representative action potential measurements
of wild-type HL-1 and shRNA transfected cells (shVAPB). J ) Analysis of the diastolic depolarization (DD duration). K) Beating
frequency of HL-1 cells under control conditions and after VAPB knock-down. L) VAPB knock-down slows the activation kinetics
(n = 5) of endogenous If currents. M) Transfection of shRNA (n = 5) shifts the voltage-dependence of activation (V1/2) of If to
more negative potentials (n = 6). N) V1/2 values for control (scrambled shRNA) were 288.2 6 3.1 mV (n = 6) and for shRNA-
transfection (shVAPB), 296.2 6 2.3 mV (n = 5), respectively. (I, J ), Scrambled shRNA was used as control. All data are presented
as means 6 SEM. The number of experiments (n) is indicated in the bar graphs. N.s., not signiﬁcant. *P , 0.05, **P , 0.01, ***P ,
0.001 [unpaired Student’s t test (D, G, H, M) or Mann-Whitney U test (E, F, J–L, N)
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DISCUSSION
Because VAPB specifically serves to increase both HCN1
and HCN2 current amplitudes, the knock-out of VAPB
results in a similar or even more severe sino-atrial brady-
cardia than knock-out of the murine HCN1 or HCN2, re-
spectively (40, 41). All HCN isoforms are expressed in the
working myocardium (38), and an unexpected contribu-
tion to the late repolarization phase of the ventricular ac-
tion potential has been postulated (38, 42, 43). In this case,
HCN32/2mice presented with strong changes in T-wave
morphology and a mild (12%) prolongation of the QT in-
terval (38). The transmural gradient, with an increased T-
wave amplitude, resulted from a shortening of the action
potential duration selective for epicardial cardiomyocytes.
This transmural effect on action potential duration
was also present in HCN12/2 mice. The mechanism be-
hind this epicardial-specific shortening of the action po-
tential duration, and why concomitantly a QT-interval
prolongation is present, remained elusive. Strikingly,
VAPB2/2mice presented a similar phenotype, indicating
thatVAPB is alsoanessential componentof theventricular
If channel complex. Thus, in the future, detailed regional
action potential studies are indicated in VAPB2/2mice
to further investigate this phenomenon. In addition,
VAPB might be relevant for inherited forms of ven-
tricular arrhythmias or for arrhythmias in heart failure,
in which increased ventricular If current densities are
discussed as a major trigger (43). Thus far, congenital
arrhythmias have only been associated with HCN4, the
predominant sino-atrial HCN transcript. It is possible
that human mutations affecting either HCN1 or HCN2
are compensated by the other isoform, preventing a
cardiac phenotype. It is conceivable that only a com-
bined reduction of HCN1 and HCN2 current in sino-
atrial cells leads to a cardiac phenotype. Similar to
Bartter syndrome type IV, in which the auditory phe-
notype is only observed when Barttin, the subunit for
both ClC-K chloride channels (ClC-Ka and ClC-Kb), is
genetically impaired (44), mutations in VAPB might be
responsible for cardiac arrhythmias thatwere not found
for HCN1 or HCN2 channels alone.
A major question arising from our results is whether
this novel function of VAPB in regulating HCN1 and
HCN2 activities could be involved in motor neuron dis-
ease. Indeed, genemutations ofVAPB have been found in
several families developingALS8, amotor neurondisease
also affecting the autonomic nervous system (33, 45). Loss
of the VAPB protein occurs in neurons frompatientswith
ALS8 (46), as well as in motor neurons of patients with
sporadic ALS (47). Importantly, the P56S mutation of
VAPB leads to a loss of HCN activity (Fig. 1T). Thus,
mutant VAPB, as well as loss of VAPB, might lower
dendritic Ih, primarily encoded by HCN1 and HCN2 in
motor neurons (48, 49), thereby decreasing excitability
of motor neurons. Indeed, increasing motor neuron
excitability is protective for motor neurons during
ALS (50, 51) (as reviewed by Roselli et al. [52]). Thus, the
loss of VAPB in motor neurons, although not suffi-
cient to trigger ALS in mice or zebrafish (27), could
substantially contribute to motor neuron degeneration
through decreased excitability. Conversely, the effects
might vary according to neuron type and brain region.
For instance, in the cortex and hippocampus, loss of
dendritically localized Ih is expected to lead to a
hyperexcitability.
Arrhythmias and sudden cardiac death are common in
ALS (53). Sudden cardiac death is responsible for;20%of
the death cases in patients with ALS (54, 55). Patients with
ALS experience prolonged QTc intervals with increased
QTc dispersion (54), a dysregulation of the heart rate (56),
and have a 25% increased prevalence for atrio-ventricular
block (57). However, VAPB mutations are very rare, and
only 1Brazilian familyhasbeen investigated in-depth (58).
In this family, there was no evidence of cardiac arrhyth-
mia, and, to our knowledge, no patient with a VAPB
mutation and typical ALS, as described byNishimura et al.
(33), has been studied for cardiac function. Conversely,
because VAPA and VAPB are reduced in patients with
ALS (35), a dysregulation of HCN channels might also be
relevant for sporadic or other familial forms of ALS. The
arrhythmias and effects on QTc interval are believed to
primarily result from a degeneration of sympathetic neu-
rons of the intermediolateral nucleus (54). Thus, a reduced
sympathetic activity could mask an intrinsic bradycardia,
due to a dysregulation of HCN channels. In addition, in
patientswithALS, afflictedbya severe and life-threatening
disorder and with the motor symptoms dominating, a
bradycardia with less psychologic strain might have fre-
quently not been brought to the attention of the physicians.
HCN channels in the brain are modulated by Trip8b
(PEX5R) (59), which reduces the cAMP responsiveness of
HCN2 and HCN4 (12) but not of HCN1 channels (60). In
addition, however, Trip8b also produces a larger increase
in maximal Ih by cAMP (61). The proximal N terminus of
Trip8b is alternatively spliced and differentially controls
HCN trafficking and function, with the most prominent
neuronal Trip8b isoform enhancing HCN1 channel sur-
face expression (62). This HCN channel modulation is
mediated by an interaction with the CNBD (63) or the
distal C terminus (59), whereas the entire C terminus is
dispensable for the interaction of HCN1 and HCN2 with
VAPB. Thus, although VAPB and Trip8b both serve to
increase surface expression of HCN channels, they act via
different binding domains. In addition, VAPB does not
cause a modulation of the cAMP responsiveness of HCN
channels. Although the 2 proteins bind to different re-
gions of the pacemaker channels, it prompts analysis of
whether these subunits act in a synergistic manner or
whether there is functional interplay with the Trip8b ef-
fects on channel gating.
We summarize that VAPB is an essential regulator of
neuronal and cardiac pacemaker channels, modulating
the surface expression and cellular localization of HCN2
and HCN1 channels. Therefore, VAPB is likely to play a
role in HCN-mediated processes such as the regulation
of cellular excitability, dendritic integration, and trans-
mission of synaptic potentials (64). VAPB modulation
of HCN channels might be highly relevant for our un-
derstandingofmanydiseases suchas cardiacarrhythmias,
epilepsies, inflammatory or neuropathic pain, and ALS
(33, 64).
VAPB A NOVEL HCN CHANNEL SUBUNIT 6171
Downloaded from www.fasebj.org by Univ of Birmingham Barnes Medical Library (147.188.108.18) on August 27, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 6159-6173.
ACKNOWLEDGMENTS
The authors thank Oxana Nowak and Andrea Schubert for
technical assistance, Nikolaj Klo¨cker (Heinrich Heine Univer-
sity Du¨sseldorf, Du¨sseldorf, Germany) for the EGFPHCN2HAEx
construct and technical advice on the ELISA assays, Caspar
Hoogenraad (Utrecht University, Utrecht, Netherlands) for the
HAVAPB construct, Bernd Fakler (University of Freiburg,
Freiburg, Germany) for the HCN1 and HCN2 pBF1 constructs,
and Vijay Renigunta (Philipps-University Marburg, Marburg,
Germany) for the HCN4-pBR3-N construct and technical advice
on the Y2H screen. The authors thank Omer Guran (University
of Birmingham) for expert help with blinded ECG analysis. L.F.
was supported, in part, by the Atrial Fibrillation Network
(AFNET), (CATCHME European Research Consortium; 633196),
the British Heart Foundation (FS/13/43/30324), and the
Leducq Foundation. T.B. was supported by a IZKF Mu¨nster
grant (Bud3/001/016). S.R. and A.K.K. were supported by a
Research Grant of the University Medical Center Giessen and
Marburg (UKGM). This work was supported by a grant of the
Deutsche Forschungsgemeinschaft (DE 1482/2-1) to N.D. The
authors declare no conﬂicts of interest.
AUTHOR CONTRIBUTIONS
N. Silbernagel, K. S. Vowinkel, M. A. Komadowski, and
K.Wemho¨ner performed TEVC recordings; A. K. Kiper,
M.Schewe, andT.Baukrowitz conductedmacropatch-clamp
recordings; N. Silbernagel and N. D. Ullrich performed and
supervised patch-clamp experiments with iPSC-CMs;
N. Silbernagel performed patch-clamp experiments in
HL-1 cells; L. A. Matschke performed experiments in
HEK293 cells; M. Zobeiri and T. Budde performed slice
patch-clamp experiments of the Pir and the thalamus; M.
Walecki performed yeast experiments; N. Silbernagel and S.
Rinne´ conductedGSTpull-downs;N.SilbernagelandS.Rinne´
conducted HCN2 surface expression assays; N. Silbernagel,
A.M.Dolga,andL.A.Matschkeperformed imagingof cortical
neurons; M. Zobeiri performed imaging of the Pir;
N. Silbernagel performed ﬂuorescence imaging experiments;
M. Kessler and S. Just performed zebraﬁsh experiments;
N. Silbernagel, M. K.-H. Scha¨fer, and M. A. Komadowski
conducted ISH; J. Scekic-Zahirovic and L. Dupuis bred,
characterized, and provided the VAPB2/2 mice; L.
Fortmu¨ller, L. Monassier, and L. Fabritz performed and
analyzed ECG recordings; N. Decher conceived the study;
N. Silbernagel and N. Decher conceived of the concept
and design and wrote the manuscript; and all authors
critically read and approved the manuscript.
REFERENCES
1. Biel, M., Schneider, A., and Wahl, C. (2002) Cardiac HCN channels:
structure, function, and modulation. Trends Cardiovasc. Med. 12,
206–212
2. Santoro, B., Liu,D. T., Yao,H., Bartsch,D., Kandel, E. R., Siegelbaum,
S. A., and Tibbs, G. R. (1998) Identiﬁcation of a gene encoding a
hyperpolarization-activated pacemaker channel of brain. Cell 93,
717–729
3. DiFrancesco, D. (1993) Pacemaker mechanisms in cardiac tissue.
Annu. Rev. Physiol. 55, 455–472
4. Pape, H. C., and McCormick, D. A. (1989) Noradrenaline and
serotonin selectively modulate thalamic burst ﬁring by enhancing a
hyperpolarization-activated cation current. Nature 340, 715–718
5. Kanyshkova, T., Pawlowski, M., Meuth, P., Dube´, C., Bender, R. A.,
Brewster,A. L., Baumann,A., Baram,T.Z., Pape,H.C., andBudde,T.
(2009) Postnatal expression pattern of HCN channel isoforms in
thalamic neurons: relationship to maturation of thalamocortical
oscillations. J. Neurosci. 29, 8847–8857
6. Beaumont, V., and Zucker, R. S. (2000) Enhancement of synaptic
transmission by cyclic AMP modulation of presynaptic Ih channels.
Nat. Neurosci. 3, 133–141
7. Williams, S. R., and Stuart, G. J. (2000) Site independence of EPSP
time course is mediated by dendritic I(h) in neocortical pyramidal
neurons. J. Neurophysiol. 83, 3177–3182
8. Ludwig,A., Zong,X., Jeglitsch,M.,Hofmann,F., andBiel,M. (1998)A
family of hyperpolarization-activated mammalian cation channels.
Nature 393, 587–591
9. Zolles, G., Klo¨cker, N., Wenzel, D., Weisser-Thomas, J., Fleischmann,
B. K., Roeper, J., and Fakler, B. (2006) Pacemaking byHCN channels
requires interaction with phosphoinositides. Neuron 52, 1027–1036
10. DiFrancesco, D., and Tortora, P. (1991) Direct activation of cardiac
pacemaker channels by intracellular cyclic AMP.Nature 351, 145–147
11. Saponaro, A., Pauleta, S. R., Cantini, F., Matzapetakis,M., Hammann,
C.,Donadoni, C.,Hu,L., Thiel,G., Banci, L., Santoro,B., andMoroni,
A. (2014) Structural basis for the mutual antagonism of cAMP and
TRIP8b in regulatingHCNchannel function.Proc.Natl. Acad. Sci. USA
111, 14577–14582
12. Zolles, G., Wenzel, D., Bildl, W., Schulte, U., Hofmann, A., Mu¨ller,
C. S., Thumfart, J.O., Vlachos, A., Deller, T., Pfeifer, A., Fleischmann,
B. K., Roeper, J., Fakler, B., and Klo¨cker, N. (2009) Association with
the auxiliary subunit PEX5R/Trip8b controls responsiveness ofHCN
channels to cAMP and adrenergic stimulation. Neuron 62, 814–825
13. Soussan, L., Burakov,D., Daniels,M. P., Toister-Achituv,M., Porat, A.,
Yarden, Y., and Elazar, Z. (1999) ERG30, a VAP-33-related protein,
functions in protein transport mediated by COPI vesicles. J. Cell Biol.
146, 301–311
14. Skehel, P. A., Martin, K. C., Kandel, E. R., and Bartsch, D. (1995) A
VAMP-binding protein from Aplysia required for neurotransmitter
release. Science 269, 1580–1583
15. Foster, L. J.,Weir,M. L., Lim,D. Y., Liu, Z., Trimble,W. S., andKlip, A.
(2000) A functional role for VAP-33 in insulin-stimulated GLUT4
trafﬁc. Trafﬁc 1, 512–521
16. Lev, S., Ben Halevy, D., Peretti, D., and Dahan, N. (2008) The VAP
protein family: from cellular functions to motor neuron disease.
Trends Cell Biol. 18, 282–290
17. Nishimura, Y., Hayashi, M., Inada, H., and Tanaka, T. (1999)
Molecular cloning and characterization of mammalian homologues
of vesicle-associatedmembraneprotein-associated (VAMP-associated)
proteins. Biochem. Biophys. Res. Commun. 254, 21–26
18. Skehel, P. A., Fabian-Fine, R., and Kandel, E. R. (2000)Mouse VAP33
is associated with the endoplasmic reticulum andmicrotubules. Proc.
Natl. Acad. Sci. USA 97, 1101–1106
19. Lvov, A., Chikvashvili, D., Michaelevski, I., and Lotan, I. (2008)
VAMP2 interacts directly with the N terminus of Kv2.1 to enhance
channel inactivation. Pﬂugers Arch. 456, 1121–1136
20. Renigunta, V., Fischer, T., Zuzarte, M., Kling, S., Zou, X., Siebert, K.,
Limberg, M. M., Rinne´, S., Decher, N., Schlichtho¨rl, G., and Daut, J.
(2014) Cooperative endocytosis of the endosomal SNARE protein
syntaxin-8 and the potassium channel TASK-1. Mol. Biol. Cell 25,
1877–1891
21. Friedrich, C., Rinne´, S., Zumhagen, S., Kiper, A. K., Silbernagel, N.,
Netter, M. F., Stallmeyer, B., Schulze-Bahr, E., and Decher, N. (2014)
Gain-of-function mutation in TASK-4 channels and severe cardiac
conduction disorder. EMBO Mol. Med. 6, 937–951
22. Dolga, A. M., Terpolilli, N., Kepura, F., Nijholt, I. M., Knaus, H. G.,
D’Orsi, B., Prehn, J. H., Eisel, U. L., Plant, T., Plesnila, N., and
Culmsee, C. (2011) KCa2 channels activation prevents [Ca2+]i
deregulation and reduces neuronal death following glutamate
toxicity and cerebral ischemia. Cell Death Dis. 2, e147
23. Westerﬁeld, M. (1993) The Zebraﬁsh Book; a Guide for the Laboratory Use of
Zebraﬁsh (Brachydanio rerio), University of Oregon Press, Eugene, OR,
USA
24. Keßler, M., Berger, I. M., Just, S., and Rottbauer, W. (2015) Loss of
dihydrolipoyl succinyltransferase (DLST) leads to reduced resting
heart rate in the zebraﬁsh. Basic Res. Cardiol. 110, 14
25. Langenbacher, A. D., Dong, Y., Shu, X., Choi, J., Nicoll, D. A.,
Goldhaber, J. I., Philipson, K. D., and Chen, J. N. (2005)Mutation in
sodium-calcium exchanger 1 (NCX1) causes cardiac ﬁbrillation in
zebraﬁsh. Proc. Natl. Acad. Sci. USA 102, 17699–17704
26. Meder, B., Scholz, E. P., Hassel, D., Wolff, C., Just, S., Berger, I. M.,
Patzel, E., Karle, C., Katus, H. A., and Rottbauer, W. (2011)
6172 Vol. 32 November 2018 SILBERNAGEL ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by Univ of Birmingham Barnes Medical Library (147.188.108.18) on August 27, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 6159-6173.
Reconstitution of defective protein trafﬁcking rescues Long-QT syn-
drome in zebraﬁsh. Biochem. Biophys. Res. Commun. 408, 218–224
27. Kabashi, E., El Oussini, H., Bercier, V., Gros-Louis, F., Valdmanis,
P. N., McDearmid, J., Mejier, I. A., Dion, P. A., Dupre, N., Hollinger,
D., Sinniger, J., Dirrig-Grosch, S., Camu, W., Meininger, V., Loefﬂer,
J. P., Rene´, F., Drapeau, P., Rouleau, G. A., and Dupuis, L. (2013)
Investigating the contribution of VAPB/ALS8 loss of function in
amyotrophic lateral sclerosis.Hum. Mol. Genet. 22, 2350–2360
28. Sartiani, L., Bochet, P., Cerbai, E., Mugelli, A., and Fischmeister, R.
(2002)Functional expressionof thehyperpolarization-activated,non-
selective cation current I(f) in immortalized HL-1 cardiomyocytes.
J. Physiol. 545, 81–92
29. Decher, N., Ortiz-Bonnin, B., Friedrich, C., Schewe, M., Kiper, A. K.,
Rinne´, S., Seemann, G., Peyronnet, R., Zumhagen, S., Bustos, D.,
Kockska¨mper, J., Kohl, P., Just, S., Gonza´lez, W., Baukrowitz, T.,
Stallmeyer, B., and Schulze-Bahr, E. (2017) Sodium permeable and
“hypersensitive” TREK-1 channels cause ventricular tachycardia.
EMBOMol. Med. 9, 403–414
30. Johnsson, N., and Varshavsky, A. (1994) Split ubiquitin as a sensor of
protein interactions in vivo.Proc. Natl. Acad. Sci. USA 91, 10340–10344
31. Weimbs, T., Low, S. H., Chapin, S. J., Mostov, K. E., Bucher, P., and
Hofmann, K. (1997) A conserved domain is present in different
families of vesicular fusion proteins: a new superfamily. Proc. Natl.
Acad. Sci. USA 94, 3046–3051
32. Weir, M. L., Klip, A., and Trimble, W. S. (1998) Identiﬁcation of a
human homologue of the vesicle-associated membrane protein
(VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed
protein that binds to VAMP. Biochem. J. 333, 247–251
33. Nishimura, A. L., Mitne-Neto, M., Silva, H. C., Richieri-Costa, A.,
Middleton, S., Cascio, D., Kok, F., Oliveira, J. R., Gillingwater, T.,
Webb, J., Skehel, P., and Zatz, M. (2004) A mutation in the vesicle-
trafﬁcking protein VAPB causes late-onset spinal muscular atrophy
and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 822–831
34. Chen, J., Mitcheson, J. S., Lin, M., and Sanguinetti, M. C. (2000)
Functional roles of charged residues in the putative voltage sensor of
the HCN2 pacemaker channel. J. Biol. Chem. 275, 36465–36471
35. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M. O.,
Akhmanova, A., Jaarsma, D., and Hoogenraad, C. C. (2007) Motor
neurondisease-associatedmutantvesicle-associatedmembraneprotein-
associated protein (VAP) B recruits wild-type VAPs into endoplasmic
reticulum-derived tubular aggregates. J. Neurosci. 27, 9801–9815
36. Gkogkas,C.,Middleton, S.,Kremer,A.M.,Wardrope,C.,Hannah,M.,
Gillingwater, T. H., and Skehel, P. (2008) VAPB interacts with and
modulates the activity of ATF6. Hum. Mol. Genet. 17, 1517–1526
37. Doherty, G. J., and McMahon, H. T. (2009) Mechanisms of
endocytosis. Annu. Rev. Biochem. 78, 857–902
38. Fenske, S., Mader, R., Scharr, A., Paparizos, C., Cao-Ehlker, X.,
Michalakis, S., Shaltiel, L., Weidinger, M., Stieber, J., Feil, S., Feil, R.,
Hofmann, F., Wahl-Schott, C., and Biel, M. (2011)HCN3 contributes
to the ventricular actionpotential waveform in themurineheart.Circ.
Res. 109, 1015–1023
39. Claycomb, W. C., Lanson, N. A., Jr., Stallworth, B. S., Egeland, D. B.,
Delcarpio, J. B., Bahinski, A., and Izzo, N. J., Jr. (1998) HL-1 cells: a
cardiac muscle cell line that contracts and retains phenotypic char-
acteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. USA 95,
2979–2984
40. Fenske, S., Krause, S. C., Hassan, S. I., Becirovic, E., Auer, F., Bernard, R.,
Kupatt,C.,Lange,P.,Ziegler,T.,Wotjak,C.T.,Zhang,H.,Hammelmann,
V., Paparizos, C., Biel, M., and Wahl-Schott, C. A. (2013) Sick sinus
syndrome in HCN1-deﬁcient mice. Circulation 128, 2585–2594
41. Ludwig, A., Budde, T., Stieber, J., Moosmang, S., Wahl, C., Holthoff,
K., Langebartels, A.,Wotjak, C.,Munsch, T., Zong,X., Feil, S., Feil, R.,
Lancel, M., Chien, K. R., Konnerth, A., Pape, H. C., Biel, M., and
Hofmann, F. (2003) Absence epilepsy and sinus dysrhythmia inmice
lacking the pacemaker channel HCN2. EMBO J. 22, 216–224
42. Fenske, S., Krause, S., Biel,M., andWahl-Schott, C. (2011)The role of
HCN channels in ventricular repolarization. Trends Cardiovasc. Med.
21, 216–220
43. Hofmann, F., Fabritz, L., Stieber, J., Schmitt, J., Kirchhof, P., Ludwig,
A., andHerrmann, S. (2012)VentricularHCNchannelsdecrease the
repolarization reserve in the hypertrophic heart. Cardiovasc. Res. 95,
317–326
44. Este´vez, R., Boettger, T., Stein, V., Birkenha¨ger, R., Otto, E.,
Hildebrandt, F., and Jentsch, T. J. (2001) Barttin is a Cl- channel
beta-subunit crucial for renal Cl- reabsorption and inner ear K+ se-
cretion. Nature 414, 558–561
45. Marques, V. D., and Marques, W., Jr. (2008) Neurophysiological
ﬁndings of the late-onset, dominant, proximal spinal muscular atro-
phies with dysautonomia because of the VAPB PRO56SERmutation.
J. Clin. Neurophysiol. 25, 233–235
46. Mitne-Neto, M., Machado-Costa, M., Marchetto, M. C., Bengtson,
M. H., Joazeiro, C. A., Tsuda, H., Bellen, H. J., Silva, H. C., Oliveira,
A. S., Lazar, M., Muotri, A. R., and Zatz, M. (2011) Downregulation of
VAPBexpression inmotor neurons derived from inducedpluripotent
stem cells of ALS8 patients. Hum. Mol. Genet. 20, 3642–3652
47. Anagnostou, G., Akbar, M. T., Paul, P., Angelinetta, C., Steiner, T. J.,
and de Belleroche, J. (2010) Vesicle associated membrane protein B
(VAPB) is decreased in ALS spinal cord. Neurobiol. Aging 31, 969–985
48. Pape,H.C. (1996)Queercurrentandpacemaker: thehyperpolarization-
activated cation current in neurons. Annu. Rev. Physiol. 58,
299–327
49. Chen, X., Sirois, J. E., Lei, Q., Talley, E. M., Lynch III, C., and Bayliss,
D. A. (2005) HCN subunit-speciﬁc and cAMP-modulated effects of
anesthetics on neuronal pacemaker currents. J. Neurosci. 25, 5803–5814
50. Saxena, S., Roselli, F., Singh, K., Leptien, K., Julien, J. P., Gros-Louis,
F., and Caroni, P. (2013) Neuroprotection through excitability and
mTOR required in ALS motoneurons to delay disease and extend
survival. Neuron 80, 80–96
51. Leroy, F., Lamotte d’Incamps, B., Imhoff-Manuel, R. D., and Zytnicki,
D. (2014) Early intrinsic hyperexcitability does not contribute to
motoneuron degeneration in amyotrophic lateral sclerosis. eLife 3
52. Roselli, F., and Caroni, P. (2015) From intrinsic ﬁring properties to
selective neuronal vulnerability in neurodegenerative diseases.
Neuron 85, 901–910
53. Finsterer, J., Sto¨llberger, C., and Maeztu, C. (2016) Sudden cardiac
death in neuromuscular disorders. Int. J. Cardiol. 203, 508–515
54. Asai, H., Hirano, M., Udaka, F., Shimada, K., Oda, M., Kubori, T.,
Nishinaka, K., Tsujimura, T., Izumi, Y., Konishi, N., Matsumoto, S.,
Kameyama, M., and Ueno, S. (2007) Sympathetic disturbances
increase risk of sudden cardiac arrest in sporadic ALS. J. Neurol. Sci.
254, 78–83
55. Shimizu, T., Hayashi, H., Kato, S., Hayashi, M., Tanabe, H., and Oda,
M. (1994) Circulatory collapse and sudden death in respirator-
dependent amyotrophic lateral sclerosis. J. Neurol. Sci. 124, 45–55
56. Murata, Y.,Harada, T., Ishizaki, F., Izumi, Y., andNakamura, S. (1997)
An abnormal relationship between blood pressure and pulse rate in
amyotrophic lateral sclerosis. Acta Neurol. Scand. 96, 118–122
57. Shemisa, K., Kaelber, D., Parikh, S. A., and Mackall, J. A. (2014)
Autonomic etiology of heart block in amyotrophic lateral sclerosis: a
case report. J. Med. Case Reports 8, 224
58. Marques,V.D.,Barreira,A.A.,Davis,M.B.,Abou-Sleiman,P.M., Silva,
W. A., Jr., Zago, M. A., Sobreira, C., Fazan, V., and Marques, W., Jr.
(2006) Expanding the phenotypes of the Pro56Ser VAPB mutation:
proximal SMA with dysautonomia.Muscle Nerve 34, 731–739
59. Santoro,B.,Wainger,B. J., andSiegelbaum,S.A. (2004)Regulationof
HCN channel surface expression by a novel C-terminal protein-
protein interaction. J. Neurosci. 24, 10750–10762
60. Santoro, B., Piskorowski, R. A., Pian, P., Hu, L., Liu, H., and
Siegelbaum, S. A. (2009) TRIP8b splice variants form a family of
auxiliary subunits that regulate gating and trafﬁcking of HCN
channels in the brain. Neuron 62, 802–813
61. Hu, L., Santoro, B., Saponaro, A., Liu, H., Moroni, A., and Siegelbaum,
S. (2013) Binding of the auxiliary subunit TRIP8b to HCN channels
shifts the mode of action of cAMP. J. Gen. Physiol. 142, 599–612
62. Lewis, A. S., Schwartz, E., Chan, C. S., Noam, Y., Shin,M.,Wadman,
W. J., Surmeier, D. J., Baram, T. Z., Macdonald, R. L., and
Chetkovich, D.M. (2009) Alternatively spliced isoforms of TRIP8b
differentially control h channel trafﬁcking and function.
J. Neurosci. 29, 6250–6265
63. Han, Y., Noam, Y., Lewis, A. S., Gallagher, J. J., Wadman,W. J., Baram,
T. Z., and Chetkovich, D. M. (2011) Trafﬁcking and gating of
hyperpolarization-activated cyclic nucleotide-gated channels are
regulated by interaction with tetratricopeptide repeat-containing
Rab8b-interacting protein (TRIP8b) and cyclic AMP at distinct sites.
J. Biol. Chem. 286, 20823–20834
64. DiFrancesco, J. C., and DiFrancesco, D. (2015) Dysfunctional HCN
ion channels in neurological diseases. Front. Cell. Neurosci. 6, 174
Received for publication February 5, 2018.
Accepted for publication May 7, 2018.
VAPB A NOVEL HCN CHANNEL SUBUNIT 6173
Downloaded from www.fasebj.org by Univ of Birmingham Barnes Medical Library (147.188.108.18) on August 27, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 6159-6173.
